http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Marvel Biosciences signs letter of intent for Phase 1 trial of MB-204
-
Carolina Rush adds 44-acre A1 gold prospect to Jefferson Project
-
Portillo's and Oreo launch three limited-time dessert items
-
Aviat Networks signs India manufacturing deal with Dixon
-
Korro Bio doses first cohort in Phase 1/2 trial for KRRO-121
-
Guardant Health study links liquid biopsy test to melanoma recurrence risk
-
AMTD's TGE in talks to acquire a Times Square-area hotel
-
Ardelyx to present three posters at ASN Kidney Week 2026
-
Revolution Medicines starts Phase 3 trial of drug combo for pancreatic cancer
-
Benton Resources acquires land, updates Dominion Project trenching
-
HII names Greg Ennis CFO of Mission Technologies division
-
Duke Robotics names Avi Levin as CFO, succeeding Shlomo Zakai
-
Interactive Brokers reports September 2026 brokerage metrics
-
Vishay launches four SOT-227 power modules with 650V MOSFET tech
-
Kinetic partners with STL to deploy plug-and-play fiber technology
-
EMA validates PolyPid's marketing application for D-PLEX100
-
PolyPid regains European rights to D-PLEX100 after ADVANZ deal ends
-
DeFi Technologies' Valour unit reports $640M in AUM, up 61%
-
Ladybug Resource Group outlines fiscal 2027 expansion roadmap
-
Q32 Bio presents Phase 2a alopecia areata trial data at EADV 2026
-
Merck's tulisokibart meets goals in skin disease Phase 2b trial
-
Worksport lists COR portable energy system on Amazon
-
HII wins U.S. Navy contract to build 10 Romulus unmanned vessels
-
Marvel Biosciences closes private placement raising $1.6 million
-
HII wins $5.1B contract to overhaul USS Harry S. Truman
-
HII's Newport News unit reaches preliminary acceptance of CVN 79
-
NetApp to honor NFL, fund Per Scholas cybersecurity training
-
Vishay launches automotive-grade power resistor in TO-263 package
-
Veracyte's Decipher test predicts hormone therapy benefit in prostate cancer
-
Ainos delivers 1,400 AI Nose units to ASE under $2.1M contract
-
Nasus Pharma doses first patient in Phase 1 NS003 nasal study
-
Criterium Energy nears first gas at SE-MGH as pipeline work wraps up
-
Realbotix names fractional CMO ahead of Echo robot launch
-
Arrowhead Pharmaceuticals to hold ARO-MAPT webinar Oct. 14
-
SoftServe joins Akamai's Partner Connect program
-
Evotec CSO Cord Dohrmann to step down after 16 years
-
PreveCeutical plans private placement to raise up to $600,000
-
French agency report cites 22nd Century Group as sole maker of low-nicotine cigarettes
-
Soluna and Bitdeer expand Bitcoin mining deal to 35 MW in Texas
-
FDA awards Palvella third year of orphan products grant funding
-
GoldInxs Mining launches $1.15M private placement offering
-
Merck licenses oral cancer drug candidate for up to $2.13 billion
-
Merck and Daiichi Sankyo withdraw lung cancer drug application
-
Rocky Shore Gold raises C$3.2M in first tranche of private placement
-
TTGI plans C$3.5M private placement and C$2M debt settlement
-
Core Scientific names Jay Elms as chief commercial officer
-
FDA approves Merck and Eisai kidney cancer combination therapy
-
22nd Century Group urges FDA to finalize nicotine reduction rule
-
Belden to manufacture Ruckus ICX switches at India facility
-
Vishay launches four thick film resistor sample kits for high power designs
